Wie sind die Öffnungszeiten?

Montag 08:00 - 12:00 13:00 - 17:00 Dienstag 08:00 - 12:00 13:00 - 17:00 Mittwoch 08:00 - 12:00 13:00 - 17:00 Donnerstag 08:00 - 12:00 13:00 - 17:00 Freitag 08:00 - 12:00 13:00 - 17:00

Geistlich Ortho

Startseite
Schweiz
Wolhusen
Geistlich Ortho

Geistlich is specialised in biomaterials for the regeneration of bone and cartilage.

06/01/2026

Happy New Year!

2026 is here—a year full of opportunities to connect, share expertise, and advance cartilage regeneration together.

At Geistlich, this year we look forward to engaging with you through:

• International Congresses - Come and meet us at our booth and attend our Corporate Symposia to exchange insights and clinical experience.

• Partnering Events – Join exclusive training sessions organized by leading societies, where Geistlich contributes as a partner to foster knowledge exchange and surgical skills development.

• Geistlich Medical Education – By attending our specialized training programs, you can take your surgical skills and expertise to the next level and ensure the highest standard of care for your patients.

Let’s make 2026 a year of collaboration, continuous education, and shaping the future of regeneration—together!

You can find all details about our presence at congresses, partnering events, and courses through this link:
https://www.geistlich.com/orthopedic/courses-and-congresses-orthopedic

09/12/2025

Only a few days to go until the next EFAS Skills Course in Augsburg

📍 University Hospital Augsburg, Stenglinstraße 2, Allemagne, 86156, Germany
📅 13–14 December 2025

Geistlich will be present as a partner, with Steven Kramer and Michael Uffelmann attending the event.

We’re looking forward to a high-level course on Hindfoot — with engaging theoretical and practical sessions led by an international faculty.

🔗https://www.efas.net/members/events-area/eventid/133/e/efas-hindfoot-13-dec-2025

02/12/2025

Live AMIC Surgery at AO Davos Courses - What an incredible experience at one of the world’s premier educational events in Davos!

At the AO Sports Courses 2025, Geistlich Ortho proudly hosted a live surgery demonstration of the AMIC® procedure for treating bifocal cartilage lesions in the knee.
The technique was performed in the impressive Rimasys mobile operating theatre by two renowned experts:
Prof. Dr. med. univ. Elmar Herbst and Prof. Dr. med. Christoph Kittl from Münster University Hospital (GER).

👉 Interested in learning more about single-stage cartilage treatment?
📩 Contact us – we are happy to support your cases and share our hashtag

AO Davos Courses: An environment where education, innovation, and collaboration come together to advance patient care.

27/11/2025

⛷️ Will you be attending the AO Sports Advanced Course on Knee Injuries and Deformities in Davos from November 30 to December 3, 2025?

👉 Join the industry-sponsored lunch session in the SHARD
🗓️ Monday, December 1, 2025 | 12:30 – 13:05

🎥 Prof. Dr. med. univ. Elmar Herbst, PhD and Prof. Dr. med. Christoph Kittl MD(Res) will demonstrate the well-established AMIC® technique for bifocal, full-thickness cartilage lesions in the knee — combining science, clinical outcomes, and practical expertise.

This session offers a unique mix of science and practice: you will have the opportunity to watch live how the experts share key practical insights during the surgical demonstration at the specimen

🤝 The Geistlich Ortho team — David Wemans, Evelyne Hasler, Laura Prospero, and Matthias Dunkel — looks forward to meeting you in Davos!

Geistlich is proud to be a partner in this course organized by the internationally recognized AO Foundation, which focuses on a comprehensive approach to knee surgery — combining clinical decision-making, surgical techniques, and hands-on training for managing complex knee disorders.

12/11/2025

Only a few days to go until the next EFAS Skills Course in Krakow!

📍 Krakow
📅 14–15 November 2025

Geistlich will be present as a partner, with our colleague Arpad Kassa attending the event.

We’re looking forward to a high-level course on tendon, ligament, and cartilage surgery — with engaging theoretical and practical sessions led by an international faculty.

🔗 https://tinyurl.com/48739j85

07/11/2025

An inspiring day at the IBRA Master Course in Basel! ✨

A big thank you to the IBRA Institute for the outstanding collaboration and the excellent, well-organized IBRA Master Course “Challenges in Foot and Ankle Surgery”. 🙌

Special thanks to the Chairman Victor Valderrabano and to all the faculty for the excellent topics covered, the interesting case presentations, and the nice discussions that made the day really engaging. 💬

Among the many insightful topics discussed, it was great to see the Geistlich Chondrogide Membrane included in the context of foot and ankle surgery.

Events like this continue to push the boundaries of innovation and excellence in surgical education. 👏

20/10/2025

Geistlich is proud to be a partner of the IBRA Master Course: Challenges in Foot & Ankle Surgery!

📍 Basel | November 7–8, 2025

Hosted at the IBRA Institute, this advanced two-day course—led by Prof. Dr. med. Dr. phil Victor Valderrabano and an international faculty—combines in-depth theory with hands-on training, featuring expert-led discussions and practical exercises for a comprehensive learning experience.

✅ For detailed information and registration, please visit:
🔗 https://www.ibra.net/events/$/Challenges-in-Foot-Ankle-Surgery/620

02/10/2025

🚨 Exciting Clinical Milestone

🦵 OrthoPure®XT from Tissue Regenix Group is a safe, off-the-shelf product in ACL Reconstruction!

The first-in-human 5-year clinical study of a novel porcine xenograft for ACL reconstruction has just been published in the Journal of Experimental Orthopaedics.

✅ Key Highlights:
- 40 patients treated with a decellularized porcine tendon graft
- No immunogenic response observed
- Clinical outcomes comparable to autografts and allografts
- Graft ruptures limited to young male patients
- MRI and radiographic results support safety and performance

This study marks a significant step forward in expanding graft options for ACL surgery, offering a biomechanically sound and immunologically safe alternative.

📄 Read the full publication in our bio!

Contact us for more information ➡️ gpag.ortho@geistlich.ch

29/09/2025

Cartilage Image of the month – September 2025 🍁🍂

🖼️ Selected as the Cartilage Image of the Month September, this case was submitted by Dr. Andrejs Finogejevs (LV).
A 42-year-old active female office worker presented with pain, stiffness, and limited knee motion for two months (VAS 4–6). Conservative treatment included NSAIDs and a knee brace. Imaging revealed a 1.5 x 2.5 cm cartilage defect on the medial femoral condyle.

Dr. Finogejevs performed a mini-open chondroplasty and microfracture. At 6 months post-op, the patient reported no pain, had returned to sports activities, and was fully weight-bearing without crutches.

At 6 months post-op, the patient was pain-free, active in sports, and walking without crutches. The one-year follow-up image shows a well-filled defect, with cartilage regeneration reaching the level of the surrounding tissue—indicating a successful outcome and excellent tissue remodeling.

25/06/2025

Mark your calendars! 📅

On 1 July, the 𝗔𝗚𝗔𝗻𝘆𝘄𝗵𝗲𝗿𝗲 𝗥𝗼𝗮𝗱𝟮𝗛𝗮𝗺𝗯𝘂𝗿𝗴 kicks off with “Move on: Patellaluxation” – an interactive online event by Winglet Community 🦵

We’re proud to support this exciting stop on the road to the AGA Congress in Hamburg!

🎟 Free registration & full details via

30/05/2025

Selected as the Cartilage Image of the Month May, this case was submitted by Dominik Wilkens (🇩🇪).

👤 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗣𝗿𝗼𝗳𝗶𝗹𝗲: 38-year-old female patient presented with an extensive retropatellar cartilage defect measuring approximately 6 cm².

👉 𝗦𝘂𝗿𝗴𝗶𝗰𝗮𝗹 𝗔𝗽𝗽𝗿𝗼𝗮𝗰𝗵: The defect was treated using a 30x40 mm collagen membrane, tailored to fit the lesion. To optimize patellar tracking and reduce lateral pressure, the procedure was complemented by a Z-plasty lengthening of the lateral retinaculum.

🔎 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗜𝗻𝘀𝗶𝗴𝗵𝘁: This case highlights the importance of addressing both the cartilage defect and biomechanical contributors to patellofemoral joint stress. The combination of membrane-based cartilage repair and soft tissue realignment offers a comprehensive approach to managing complex patellar cartilage lesions.

𝗪𝗵𝗮𝘁 𝘄𝗮𝘀 𝘆𝗼𝘂𝗿 𝗹𝗮𝘀𝘁 𝗰𝗮𝘀𝗲 𝘆𝗼𝘂 𝘁𝗿𝗲𝗮𝘁𝗲𝗱 𝘄𝗶𝘁𝗵 𝗔𝗠𝗜𝗖® 𝗖𝗵𝗼𝗻𝗱𝗿𝗼-𝗚𝗶𝗱𝗲®?

22/05/2025

🦶 A new case report presents immunohistochemical analysis of tissue samples following AMIC® for osteochondral lesions in the talus, demonstrating progressive transformation to hyaline-like cartilage over 14 to 36 months.

A big 🙏 to the authors: Fabian Krause, Helen Anwander and Schäfer Birgit!

Read the full article with the link in our bio!

Adresse

Bahnhofstrasse 40
Wolhusen

Öffnungszeiten

Montag	08:00 - 12:00
	13:00 - 17:00
Dienstag	08:00 - 12:00
	13:00 - 17:00
Mittwoch	08:00 - 12:00
	13:00 - 17:00
Donnerstag	08:00 - 12:00
	13:00 - 17:00
Freitag	08:00 - 12:00
	13:00 - 17:00

Telefon

+41414925555

Webseite

https://www.geistlich-pharma.com/de/ueber-uns/kontakt/hauptsitz/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Geistlich Ortho erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an Geistlich Ortho senden:

Verknüpfungen

Adresse
Telefon
Öffnungszeiten
Benachrichtigungen
Die Praxis Kontaktieren
Eigentum beanspruchen
oder Auflistung melden

Wollen Sie Ihr Praxis zum Top-Klinik in Wolhusen machen?

Kategorie

Pharmaunternehmen

About us

Geistlich Surgery produces innovative bio-derived matrix products for bone and cartilage, including Orthoss®, Orthoss Collagen®, and Chondro-Gide®. Our products leverage the body’s own healing potential to regenerate bone and cartilage. Our focus is on helping people maintain and regain their quality of life.

Geistlich Surgery is a business unit of Geistlich Pharma AG, which is headquartered in Switzerland. Entirely family owned since 1851, the company develops, produces, and markets medical devices for regenerative medicine and pharmaceuticals. From research and development to marketing, our operations are fully integrated under one roof, which enables us to oversee and optimize all levels of our business.